| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lipocine Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 125,000 | $33,200 | $0.2656 | 01 Nov 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LPCN | Lipocine Inc. | 01 Nov 2022 | 1 | $50,750 | 4 | Chief Medical Officer | 08 Nov 2022, 10:57 |
| LPCN | Lipocine Inc. | 01 Nov 2022 | 0 | $0 | 3 | Chief Medical Officer | 08 Nov 2022, 10:55 |